Transgene Biotek Market Cap

Transgene Biotek has a market cap or net worth of 218.22 million as of April 29, 2026. Its market cap has decreased by -25.39% in one year.

Market Cap

218.22M

Enterprise Value

382.66M

Revenue

2.33M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.88

Market Cap Chart

Since January 3, 2005, Transgene Biotek's market cap has decreased from 1.43B to 218.22M, a decrease of -84.75%. That is a compound annual growth rate of -8.44%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	218.22M	-8.57%
Dec 31, 2025	238.68M	-53.88%
Dec 31, 2024	517.51M	-30.80%
Dec 29, 2023	747.85M	234.58%
Dec 30, 2022	223.52M	-33.71%
Dec 31, 2021	337.18M	-8.81%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
KJMC Corporate Advisors (India)	215.95M
Visagar Financial Services	216.05M
Titaanium Ten Enterprise	216.05M
Command Polymers	215.66M
Salguti Industries	214.72M
Cindrella Hotels	217.22M
Shyam Telecom	214.58M
Techindia Nirman	217.33M

Market Cap Rankings